Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Lijun Xin

Market Cap

223.87 Billion HKD

Sector

Healthcare

Website

https://ir.jdhealth.com

Description

JD Health International Inc.

Read More

Overview

Value

12

Growth

76

Health

64

Management

6

Analyst Opinion

0

Total

40

All Scores Out Of 100

Best Features

  • Very strong cashflow and earnings growth
  • Has a low level of debt
  • Has a history of share buybacks
  • Has strong financial health
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Earnings growth has slowed down recently
  • Earnings are negative
  • No margin of safety at their current market price
  • Cashflow is growing faster than revenue

Market Peers

6618.HK

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-21.00%

Revenue Growth (5 Year Average)

24.11%

Ratings Consensus

N/A

Share Buybacks

10.95%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

12

  • Estimated intrinsic-value of 54.11 HKD is lower than current price ( 70.40 HKD)
  • Free-cashflow-yeild of N/A is worse than the market average (4.7%)
  • Margin-of-safety of -21.00% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 28.3 HKD

Current Price: 68.5 HKD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

N/A

PE/Earnings Growth

N/A

Price/Book

5.14x

Growth

Growth Score

76

  • 5 Year Average Revenue growth of 24.11% is higher than the market average (10.97%)
  • 5 Year Average Cashflow growth of 26.09% is higher than the market average (12.35%)
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of 12.31% is lower than the market average (14.48%)
  • Earnings growth has slowed this year
  • Free Cashflow growth has slowed this year

Revenue Growth

24.11%

Earnings Growth

12.31%

Cashflow Growth

26.09%

Health

Health Score

64

  • Has a low level of debt
  • Assets cover liabilities
  • Low financial Leverage
  • Normal operation does not require debt to be sustainable
  • Debt repayments do not significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

N/A

Debt/Equity

0.01x

Current Assets/Liabilities

5.71x

Free Cashflow/Total Debt

14.47x

Debt/Capital

0.00x

Management

Management Score

6

  • Has a history of returning value to shareholders through stock buybacks
  • Return-on-capital-employed of -1.37% is lower than the market average (10%)
  • Has repurchased shares when overvalued
  • Return-on-equity of -3.88% is lower than the market average (15%)

Average Buybacks/Dilution

10.95%

Recent Buybacks/Dilution

43.98%

5 Year Price Volitility

30.71%

Return On Assets

-3.22%

Return On Capital Employed

-1.37%

Return On Equity

-3.88%

Return On Free Cashflow

-42.22%

Return On Investments

-131.11%

Analysts

Analyst Opinion

0

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    Other Information

    Company Name

    JD Health International Inc.

    Currency

    HKD

    Beta

    0.650612

    Vol Avg

    10486973

    Ceo

    Mr. Lijun Xin

    Cik

    Cusip

    Exchange

    HKSE

    Full Time Employees

    2540

    Industry

    Medical Care Facilities

    Sector

    Healthcare

    Ipo Date

    2020-12-08

    Address

    Building C, 8th Floor

    City

    Beijing

    State

    Country

    CN

    Zip

    101111

    Phone

    All financial data provided by FMP

    Noticed an error with something on our site?

    We Use Cookies